Business ❯ Corporate Governance ❯ Shareholder Relations

Ownership Structure

EP Group Family Businesses TCL Holdings Stake Acquisition Combined Firm Ownership Market Capitalization Majority Shareholders Stakeholder Engagement Stock Exchange Listings Majority Stake

Aethlon Agrees to All-Stock Merger to Take North Immunology Public

An oversubscribed $180 million PIPE will fund the combined company’s lead drug NOR-101 as it moves into Phase 1a and key readouts through 2028.

HNI and Steelcase Launch Integration Following $2.2 Billion Acquisition Agreement